Brexit prompts amendment to CSP Regulations
By EsqSocial Corporation 21/01/21
On December 21, 2020, the Certificate of Supplementary Protection Regulations were amended to add the United Kingdom as a “prescribed country” for the purpose of determining the timeliness of the Certificate of Supplementary Protection (CSP) applicant’s New Drug Submission. The amendment was a consequence of Brexit; the U.K. was previously a prescribed country as a member of the European Union. The amendment came into force on January 6, 2021, and the CSP Guidance Document and Application Form...
By: Smart & Biggar